NAKAGAWA TOHRU 中川徹

… Alternative Names

NAKAGAWA Tohru 中川徹

Less

Researcher Number	40591730
Other IDs
Affiliation (Current)	2025: 帝京大学, 医学部, 教授
Affiliation (based on the past Project Information) *help	2017 – 2023: 帝京大学, 医学部, 教授 2013 – 2016: 東京大学, 医学部附属病院, 講師
Review Section/Research Field	Principal Investigator Urology Except Principal Investigator Basic Section 56030:Urology-related / Urology / Tumor therapeutics
Keywords	Principal Investigator ネオアンチゲン / 癌精巣抗原 / Tim-3 / PD-1 / 免疫チェックポイント阻害剤 / ガンマデルタT細胞 / 免疫療法 / NKG2D / γδT細胞 / CIBERSORT / 次世代シーケンサー / 腫瘍免疫 / 尿路上皮癌 … More Except Principal Investigator … More 免疫療法 / 腎細胞癌 / イムノグラム / 免疫チェックポイント阻害薬 / ペムブロリズマブ / 尿路上皮癌 / ＥＳＳ２ / ＲＯＲγ / ESS2 / RORγ / 前立腺癌 / IFNg / HLA-A2トランスジェニックマウス / MHCクラスI結合予測 / HLA-A2 トランスジェニックマウス / IFN-gamma / トランスジェニックマウス / HLA-A2 / T細胞 / MHC class I 結合予測 / ネオエピトープ / 腎がん / MHC結合予測アルゴリズム / ネオ抗原 / 遺伝子変異 / 腎癌 / クロマチン異常 / 癌進展 / クロマチン制御関連遺伝子 / 癌の進展 / クロマチン制御遺伝子 / 分子標的薬 / インターフェロン / 樹状細胞療法 Less

Tailor-made immunotherapy strategy for urothelial cancer using immunogram
- Principal Investigator
  
  Kawai Taketo
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Teikyo University
Development of immunotherapy for castration resistant prostate cancer targeting a novel cofactor of RORgamma
- Principal Investigator
  
  Takahashi Sayuri
- Project Period (FY)
  2018 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  The University of Tokyo
  Teikyo University
Development of cancer immunotherapy targeting mutation-derived neoantigens
- Principal Investigator
  
  MATSUSHITA Hirokazu
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Aichi Cancer Center Research Institute
  The University of Tokyo
Analysis of intra-tumor immune response toward development of autologous gamma-delta T-cell transfer therapy in patients with advanced urothelial carcinomaPrincipal Investigator
- Principal Investigator
  
  Nakagawa Tohru
- Project Period (FY)
  2015 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Teikyo University
  The University of Tokyo
Role of the chromatin regulating genes in the progression of renal cell carcinoma
- Principal Investigator
  
  Kume Haruki
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  The University of Tokyo
DC-based vaccination combined with interferon for metastatic renal cell carcinoma
- Principal Investigator
  
  ENOMOTO Yutaka
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  The University of Tokyo

All 2022 2019 2018 2017 2016 2015 Other

All Journal Article Presentation Other

[Journal Article] Transcriptional coregulator Ess2 controls survival of post-thymic CD4+ T cells through the Myc and IL-7 signaling pathways2022
- Author(s)
  Takada I‡, Hidano S‡, Takahashi S‡, Ogawa H, Tsuchiya M, Yokoyama A, Sato S, Ochi H, Nakagawa T, Kobayashi T, Nakagawa S, Makishima M
- Journal Title
  
  Journal of Biological Chemistry
  
  Volume: 298 Pages: 102342-102342
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K09162
[Journal Article] Clinical significance of random bladder biopsy in primary T1 bladder cancer2018
- Author(s)
  Otsuka Masafumi、Taguchi Satoru、Nakagawa Tohru、Morikawa Teppei、Maekawa Shigekatsu、Miyakawa Jimpei、Matsumoto Akihiko、Miyazaki Hideyo、Fujimura Tetsuya、Fukuhara Hiroshi、Kume Haruki、Igawa Yasuhiko、Homma Yukio
- Journal Title
  
  Molecular and Clinical Oncology
  
  Volume: 8 Pages: 665-670
- DOI
  10.3892/mco.2018.1587
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K10577, KAKENHI-PROJECT-16K10996
[Journal Article] Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine Prognosis in Clear Cell Renal Cell Carcinoma2016
- Author(s)
  Matsushita H, Sato Y, Karasaki T, Nakagawa T, Kume H, Ogawa S, Homma Y, Kakimi K
- Journal Title
  
  Cancer Immunol Res.
  
  Volume: 4 Pages: 463-71
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K07162
[Journal Article] Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine Prognosis in Clear Cell Renal Cell Carcinoma.2016
- Author(s)
  Matsushita H, Sato Y, Karasaki T, Nakagawa T, Kume H, Ogawa S, Homma Y, Kakimi K.
- Journal Title
  
  Cancer Immunol Res
  
  Volume: 未
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26462402
[Presentation] 新規RORγ転写共役因子ESS2遺伝子の同定および前立腺癌増悪のメカニズムの解明2019
- Author(s)
  高橋さゆり,久米春喜,中川徹
- Organizer
  第69回日本泌尿器科学会中部総会
- Data Source
  KAKENHI-PROJECT-18K09162
[Presentation] 核内受容体RORγの新規転写共役因子ESS2は染色体凝縮・分裂を制御し前立腺癌を増悪させる2019
- Author(s)
  高橋さゆり,山田幸央,久米春喜,中川徹
- Organizer
  日本泌尿器腫瘍学会第5回学術集会
- Data Source
  KAKENHI-PROJECT-18K09162
[Presentation] 進行性膀胱癌に対する膀胱全摘術後の補助化学療法の有用性の検討：多施設共同研究．2018
- Author(s)
  1.金谷淳志、松本明彦、川合剛人、池田勝臣、宮川仁平、田口慧、内藤晶裕、大塚真史、中西泰一、東剛司、鈴木基文、古賀文隆、近藤靖司、岡根谷利一、田中良典、久米春喜、中川徹．
- Organizer
  第106回日本泌尿器科学会総会
- Data Source
  KAKENHI-PROJECT-15K10577
[Presentation] 転移性腎細胞癌に対するスニチニブ併用樹状細胞療法2017
- Author(s)
  1.中川徹、松下博和、垣見和宏、松本明彦、宮嵜英世、藤村哲也、福原浩、榎本裕、久米春喜、本間之夫．
- Organizer
  第105回日本泌尿器科学会総会
- Data Source
  KAKENHI-PROJECT-15K10577
[Presentation] Expression of candidate neoantigens in ccRCC patients and its implication on prognosis2015
- Author(s)
  Hirokazu Matsushita, Manami Miyai, Yusuke Sato, Tohru Nakagawa, Haruki Kume, Seishi Ogawa, Yukio Homma, Kazuhiro Kakimi
- Organizer
  第19回日本がん免疫学会総会（ICCIM2015）
- Place of Presentation
  伊藤国際学術研究センター(東京都文京区)
- Year and Date
  2015-07-09
- Data Source
  KAKENHI-PROJECT-15K10577
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]

1. KAKIMI Kazuhiro (80273358)

# of Collaborated Projects: 4 results

# of Collaborated Products: 3 results
2. Kume Haruki (10272577)

# of Collaborated Projects: 4 results

# of Collaborated Products: 6 results
3. MATSUSHITA Hirokazu (80597782)

# of Collaborated Projects: 3 results

# of Collaborated Products: 3 results
4. Kawai Taketo (60343133)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
5. 山田大介 (00623696)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
6. ENOMOTO Yutaka (20280927)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. Takahashi Sayuri (40313217)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
8. 永田政義 (00323668)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 東剛司 (50719854)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. 小林隆志 (30380520)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
11. 佐藤悠佑 (20372378)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

NAKAGAWA TOHRU 中川 徹

NAKAGAWA Tohru 中川 徹

Research Projects

Research Products

Co-Researchers

Tailor-made immunotherapy strategy for urothelial cancer using immunogram

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of immunotherapy for castration resistant prostate cancer targeting a novel cofactor of RORgamma

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of cancer immunotherapy targeting mutation-derived neoantigens

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis of intra-tumor immune response toward development of autologous gamma-delta T-cell transfer therapy in patients with advanced urothelial carcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Role of the chromatin regulating genes in the progression of renal cell carcinoma

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

DC-based vaccination combined with interferon for metastatic renal cell carcinoma

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Transcriptional coregulator Ess2 controls survival of post-thymic CD4+ T cells through the Myc and IL-7 signaling pathways2022

Author(s)

Journal Title

Data Source

[Journal Article] Clinical significance of random bladder biopsy in primary T1 bladder cancer2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine Prognosis in Clear Cell Renal Cell Carcinoma2016

Author(s)

Journal Title

Data Source

[Journal Article] Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine Prognosis in Clear Cell Renal Cell Carcinoma.2016

Author(s)

Journal Title

Data Source

[Presentation] 新規RORγ転写共役因子ESS2遺伝子の同定および前立腺癌増悪のメカニズムの解明2019

Author(s)

Organizer

Data Source

[Presentation] 核内受容体RORγの新規転写共役因子ESS2は染色体凝縮・分裂を制御し前立腺癌を増悪させる2019

Author(s)

Organizer

Data Source

[Presentation] 進行性膀胱癌に対する膀胱全摘術後の補助化学療法の有用性の検討：多施設共同研究．2018

Author(s)

Organizer

Data Source

[Presentation] 転移性腎細胞癌に対するスニチニブ併用樹状細胞療法2017

Author(s)

Organizer

Data Source

[Presentation] Expression of candidate neoantigens in ccRCC patients and its implication on prognosis2015

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

NAKAGAWA TOHRU 中川徹

NAKAGAWA Tohru 中川徹